New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: PR Newswire
With chronic disease on the rise, a new survey from Abbott shows information overload, confusion and cost leave many Americans struggling, worrying about how to stay healthyABBOTT PARK, Ill., April 9, 2026 /PRNewswire/ -- Today, Abbott (NYSE: ABT), a global leader in chronic disease prevention, treatment and care, is releasing new survey findings highlighting a growing tension: 74% of U.S. adults believe most chronic diseases, such as diabetes or cardiovascular disease, are preventable, but only 1 in 4 feel very confident in knowing how to care for their health.In the U.S. alone, three in four American adults have at least one chronic condition1. With chronic disease continually on the rise2, Americans say they feel held back by health information overload, confusion and costs. The new research, conducted by leading marketing and analytics company, Kantar, found:Sixty-five percent of people say they have delayed or avoided doing something for their health because it felt too overwhelm
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [Yahoo! Finance]Yahoo! Finance
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [TheStreet.com]TheStreet.com
- Abbott Laboratories (ABT) had its price target raised by Barclays PLC from $142.00 to $144.00. They now have an "overweight" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by The Goldman Sachs Group, Inc. from $140.00 to $121.00. They now have a "buy" rating on the stock.MarketBeat
- Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- ABT's page on the SEC website